We are live on ! Find out more
JGGDR

JGP Global Gestao de Recursos Portfolio holdings

AUM $45.3M
1-Year Est. Return 42.75%
This Fund
S&P 500
This Quarter Est. Return
-11.93%
1 Year Est. Return
+42.75%
3 Year Est. Return
+205.51%
5 Year Est. Return
+441.7%
10 Year Est. Return
+707.39%
AUM
$82.3M
AUM Growth
+$23.2M
Cap. Flow
+$38M
Cap. Flow %
46.16%
Top 10 Hldgs %
81.47%
Holding
63
New
41
Increased
1
Reduced
13
Closed
8

Top Buys

Rank Stock Value
1
EWZ icon
iShares MSCI Brazil ETF
EWZ
+$19.4M
2
GE icon
GE Aerospace
GE
+$15.1M
3
OIBR.C
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
+$2.06M
4
UNH icon
UnitedHealth
UNH
+$1.56M
5
PAGS icon
PagSeguro Digital
PAGS
+$1.06M

Top Sells

Rank Stock Value
1
BUD icon
AB InBev
BUD
+$5.37M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$2.38M
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$2M
4
FTI icon
TechnipFMC
FTI
+$923K
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$431K

Sector Composition

Rank Sector Weight
1 Healthcare 21.53%
2 Industrials 14.71%
3 Communication Services 5.49%
4 Technology 0.98%
5 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXAS
26
DELISTED
Exact Sciences
EXAS
$370K 0.45%
+5,863
New +$402K
MRK icon
27
Merck
MRK
$318B
$360K 0.44%
+4,942
New +$349K
EXEL icon
28
Exelixis
EXEL
$13.4B
$339K 0.41%
17,215
-1,022
-6% -$18.2K
EW icon
29
Edwards Lifesciences
EW
$51.7B
$338K 0.41%
+6,624
New +$335K
AGN
30
DELISTED
Allergan plc
AGN
$330K 0.4%
+2,466
New +$404K
BLUE
31
DELISTED
bluebird bio
BLUE
$325K 0.39%
+253
New +$388K
ABBV icon
32
AbbVie
ABBV
$435B
$318K 0.39%
+3,454
New +$304K
ASMB icon
33
Assembly Biosciences
ASMB
$529M
$314K 0.38%
1,158
-59
-5% -$17.1K
ELV icon
34
Elevance Health
ELV
$85.5B
$309K 0.38%
+1,177
New +$324K
LLY icon
35
Eli Lilly
LLY
$1.06T
$304K 0.37%
+2,631
New +$294K
CELG
36
DELISTED
Celgene Corp
CELG
$292K 0.35%
+4,551
New +$336K
FOLD
37
DELISTED
Amicus Therapeutics
FOLD
$290K 0.35%
30,287
-1,523
-5% -$16.7K
GHDX
38
DELISTED
Genomic Health, Inc.
GHDX
$286K 0.35%
+4,438
New +$311K
AERI
39
DELISTED
Aerie Pharmaceuticals
AERI
$279K 0.34%
+7,723
New +$362K
BIIB icon
40
Biogen
BIIB
$30.7B
$257K 0.31%
+855
New +$273K
GWPH
41
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$242K 0.29%
+2,480
New +$325K
GBT
42
DELISTED
Global Blood Therapeutics, Inc.
GBT
$237K 0.29%
+5,764
New +$216K
PRQR icon
43
ProQR Therapeutics
PRQR
$265M
$235K 0.29%
14,870
-748
-5% -$13.7K
NBIX icon
44
Neurocrine Biosciences
NBIX
$16.6B
$214K 0.26%
+2,997
New +$287K
REGN icon
45
Regeneron Pharmaceuticals
REGN
$80.8B
$205K 0.25%
+548
New +$201K
ARGX icon
46
argenx
ARGX
$54.1B
$202K 0.25%
+2,100
New +$187K
BCRX icon
47
BioCryst Pharmaceuticals
BCRX
$2.4B
$191K 0.23%
23,724
-2,721
-10% -$21.2K
NTRA icon
48
Natera
NTRA
$46.4B
$171K 0.21%
12,238
-655
-5% -$12K
IMMU
49
DELISTED
Immunomedics Inc
IMMU
$169K 0.21%
11,855
-555
-4% -$11K
AMRN
50
Amarin Corp
AMRN
$303M
$150K 0.18%
+551
New +$201K
1
2
3

Similar funds

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
RRC
Range Rock Capital Wellesley, Massachusetts $46.7M AUM

JGP Global Gestao de Recursos's Q4 2018 Portfolio in Review

As of Q4 2018, JGP Global Gestao de Recursos held 63 positions worth $82.3M, up 39% from $59.1M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

JGP Global Gestao de Recursos deployed $38M of net new capital in Q4 2018, opening 41 new positions and adding to 1 existing holding. Its largest new stake was iShares MSCI Brazil ETF: 500,000 shares worth $19.1M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 14% a quarter earlier, followed by Industrials and Communication Services.

On the sell side, the largest reduction was BioMarin Pharmaceuticals, an estimated $431K trimmed.

  • JGP Global Gestao de Recursos's largest Q4 2018 buy was iShares MSCI Brazil ETF: 500,000 shares worth $19.1M.
  • JGP Global Gestao de Recursos added most to OI S.A. American Depositary Shares, each representing five shares of common stock in Q4 2018, an estimated $2.06M increase.
  • JGP Global Gestao de Recursos's biggest Q4 2018 reduction was BioMarin Pharmaceuticals, cutting an estimated $431K.
  • JGP Global Gestao de Recursos fully exited AB InBev in Q4 2018, selling an estimated $5.37M.
  • JGP Global Gestao de Recursos's ten largest holdings make up 81% of its $82.3M portfolio in Q4 2018.
  • JGP Global Gestao de Recursos opened 41 new positions and closed 8 in Q4 2018.
  • JGP Global Gestao de Recursos's portfolio value rose 39% quarter-over-quarter to $82.3M.

Based on JGP Global Gestao de Recursos's 13F filing for Q4 2018, filed 23 Jan 2019.